The study analyzed copy number alterations in 48 cancer foci from 18 prostate cancer patients to determine whether multifocal prostate cancers originate from a monoclonal or polyclonal origin. The results found identical genomic copy number changes shared among all cancer foci from the same patient in 13 cases, indicating these cancers likely originated from a single cell (monoclonal origin). However, a small fraction of cases did not share identical changes between foci, suggesting polyclonal origin cannot be ruled out. Larger sample sizes are needed to further clarify the clonal origins of multifocal prostate cancers.